Rare diseases
Investigational molecules
Locations
Back to Greece680 clinical trials in Efkarpia, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GreeceΚλινικεσΔοκιμεσ.gr(opens in a new tab)Study Comparing ABBV-383 with Standard Therapies for Adults with Relapsed or Refractory Multiple Myeloma
GreeceStudy of Pegcetacoplan (APL-2) in Patients with Transplant-associated Thrombotic Microangiopathy After Stem Cell Transplantation
GreeceStudy on the Effects of Itepekimab for Patients with Non-Cystic Fibrosis Bronchiectasis
GreeceStudy on Amlitelimab for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis Using Topical Corticosteroids and Inadequate Response to Previous Treatments
GreeceStudy of daxdilimab injection for adults with moderate to severe discoid lupus erythematosus
GreeceStudy on Long-Term Use of Spesolimab for Patients with Hidradenitis Suppurativa Who Completed a Previous Spesolimab Study
GreeceStudy of Tarlatamab for Patients with Limited-Stage Small-Cell Lung Cancer After Chemoradiotherapy
GreeceStudy of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations
GreeceStudy on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More
GreeceStudy on Giredestrant and Everolimus for Patients with Estrogen Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer
GreeceStudy of Durvalumab with Radiation Therapy for Patients with Early Stage Non-Small Cell Lung Cancer and Osimertinib for Those with EGFR Mutation
GreeceStudy of TAR-200 and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Not Undergoing Radical Cystectomy
GreeceThe busiest research cities in the country
What the registry says about research in the country
Extensive trials focusing on hidradenitis suppurativa and atopic dermatitis, evaluating novel therapeutic approaches and treatment combinations to improve patient outcomes.
Multiple studies testing new biological therapies and their long-term safety profiles.
Research centered on lupus erythematosus and Sjögren's Disease, investigating targeted therapies to manage disease progression and symptoms.
Studies aim to evaluate new therapeutic agents for better disease control.
Innovative trials examining treatments for Type 2 Diabetes and obesity, with focus on cardiovascular outcomes and weight management.
Research comparing new therapeutic options against established treatments.
Advanced research in metastatic breast cancer and colorectal cancer, evaluating targeted therapies and combination treatments.
Focus on improving progression-free survival in advanced disease stages.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
